Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction
{{output}}
Background: Dose reduction of tyrosine kinase inhibitors (TKIs) is an option for some chronic myeloid leukemia (CML) patients to minimize side effects while maintaining efficacy. Shared decision-making (SDM) and patient decision ... ...
